Biosimilar Basics Course
hosted byConnect Educate Impact (CEI)
Biosimilar Basics Course is organized by Connect Educate Impact (CEI).
Initial Release Date: October 4, 2022
Planned Expiration Date: October 4, 2025
Credit: 0.1 CEU
Description:
The development of biosimilars has been a strategy to reduce the rising cost of healthcare, particularly in the area of oncology. This course provides critical information on the approval of biosimilars, the clinical aspects of interchangeability, and the development of a collaborative process for quality care.
Objectives:
Upon successful completion of this application-based CPE course, pharmacists should be able to:
• Define key terminology related to biosimilar products.
• Explain the FDA's process for developing, reviewing, and approving biosimilars.
• Assess the impact of biosimilars on patients, payers, providers, and pharmacies in hematology/oncology practice.
• Discuss the potential effects of an interchangeability designation for a biosimilar.
• Develop a collaborative process for pharmacy team members to be more involved in substituting biosimilars.
